D
Translational Development Acquisition Corp. TDAC
$10.88 $0.040.32% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2026 03/31/2026 12/31/2025 09/30/2025 06/30/2025
Net Income 82.27% 339.64% 9,073.77% 970.40% 725.05%
Total Depreciation and Amortization -- -- -- -- --
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -80.50% -263.24% -5,953.85% -354,543.75% -237,431.25%
Change in Net Operating Assets 194.86% 136.10% 150.95% -1,846.64% -24,815.00%
Cash from Operations 32.28% 37.03% 28.55% -3,114.81% --
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 115.85% -- -- -- --
Cash from Investing 115.85% -- -- -- --
Total Debt Issued 226.89% 34.59% -50.80% -12.41% 380.71%
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- 91,614.67% --
Cash from Financing -115.23% -99.72% -99.89% 66,700.04% 250,532.29%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 237.23% -207.37% -193.65% -179.76% -152.72%